Quick answer
Core Laboratories Inc. (CLB) reported revenue of $526.5M and net income of $29.7M for the fiscal year ended 2025-12-31, up 0.5% from $523.8M the year before, per its 10-K filed with the SEC on 2026-03-23. Long-term debt stood at $113.0M.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $526.5M | $29.7M | $113.0M |
| 2024 (FY ending 2024-12-31) | $523.8M | $31.4M | $128.0M |
| 2023 (FY ending 2023-12-31) | $509.8M | $36.7M | $166.0M |
| 2022 (FY ending 2022-12-31) | $489.7M | $19.5M | $175.0M |
| 2021 (FY ending 2021-12-31) | $470.3M | $19.7M | — |
Frequently asked questions
What is Core Laboratories Inc.'s annual revenue?
Core Laboratories Inc. (CLB) reported revenue of $526.5M and net income of $29.7M for the fiscal year ended 2025-12-31, up 0.5% from $523.8M the year before, per its 10-K filed with the SEC on 2026-03-23. Long-term debt stood at $113.0M.
What is CLB's profit margin?
Core Laboratories Inc.'s net margin was 5.6% in the fiscal year ended 2025-12-31.
Related
- CINF revenue, net income and debt history (Cincinnati Financial Corporation)
- CIVB revenue, net income and debt history (Civista Bancshares, Inc.)
- CL revenue, net income and debt history (Colgate-Palmolive Company)
- CLF revenue, net income and debt history (Cleveland-Cliffs Inc.)
- CLH revenue, net income and debt history (Clean Harbors, Inc)
- CLMB revenue, net income and debt history (Climb Global Solutions, Inc.)
- CLPT revenue, net income and debt history (ClearPoint Neuro, Inc.)
- CLS revenue, net income and debt history (Celestica Inc)
Last updated Oct 23, 2026, 7:21 AM ET. Data only, not financial or tax advice.
Related answers
Tools & live data
What's Moving Right Now
#1 Nasdaq-100 moverAMD $507.93 -8.10%Nasdaq, as of Oct 22, 2026 4:15 PM ET
Trading halts18 halts in Nasdaq's current feedNasdaq Trader feed, checked Oct 23, 7:15 AM ET
Earnings & SEC 8-Ks14 companies report Oct 23 · 8-Ks todayNasdaq earnings calendar, SEC EDGAR